Jump Financial, LLC Co Diagnostics, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$8.12 - $10.37 $302,064 - $385,764	-37,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.48 - $11.38 $200,082 - $304,403	26,749 Added 255.95%	37,200 $362,000
Q2 2021 Aug 13, 2021	SELL	$7.16 - $9.56 $264,791 - $353,547	-36,982 Reduced 77.97%	10,451 $86,000
Q1 2021 May 17, 2021	BUY	$8.52 - $19.21 $290,319 - $654,580	34,075 Added 255.09%	47,433 $453,000
Q4 2020 Feb 12, 2021	BUY	$9.3 - $15.19 $124,229 - $202,908	13,358 New	13,358 $124,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.